Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3-4
|
pubmed:dateCreated |
1997-4-1
|
pubmed:abstractText |
The present study was conceived in order to recommend use of the Minnesota Multiphasic Personality Inventory for the evaluation of the personality of volunteers participating in Phase I clinical trials. The study was intended to describe personality profiles as objectively as possible, attempting to identify any common traits or tendencies, and to evaluate whether age or cultural background can be associated with significant differences in volunteer personality profiles.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0031-6970
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
51
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
209-13
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9010686-Adolescent,
pubmed-meshheading:9010686-Adult,
pubmed-meshheading:9010686-Aged,
pubmed-meshheading:9010686-Clinical Trials, Phase I as Topic,
pubmed-meshheading:9010686-Female,
pubmed-meshheading:9010686-Humans,
pubmed-meshheading:9010686-Male,
pubmed-meshheading:9010686-Middle Aged,
pubmed-meshheading:9010686-Personality Inventory
|
pubmed:year |
1996
|
pubmed:articleTitle |
Evaluation of personality as a component of the healthy condition of volunteers participating in phase I studies.
|
pubmed:affiliation |
Clinical Pharmacology, Glaxo Wellcome SpA Medicines Research Centre, Verona, Italy.
|
pubmed:publicationType |
Journal Article
|